Genialis and Inventia Life Science Collaborate to Advance Patient-Relevant Pancreatic Cancer Models Genialis, a therapeutic intelligence company, and Inventia Life Science, a developer of advanced 3D cell model technologies, have…
Allotera Therapeutics Opens MRD-Positive Cohort in Pivotal T-RRex Study of Sofi-cel for T-ALL and T-LBL Allotera Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for hematological malignancies,…
ApalyRx and Vida Health Partner to Expand Cost-Effective, Integrated Weight-Loss Care for Employers ApalyRx, a pharmacy technology platform designed to assess prescriptions in real time and route them to the…
Polaris Rx Selected Again as Exclusive U.S. Distributor for FluMist Home for 2026–2027 Flu Season Polaris Rx, a provider of long-term care, specialty and infusion pharmacy solutions, has been selected…
BioIVT to Showcase Translational Research Strategies for Metabolic Disease, GLP-1 Therapies and Emerging Drug Development Models BioIVT, a global research partner and biospecimen solutions provider supporting drug and diagnostic development,…
Pilatus Biosciences to Present Phase 1 PLT012 Clinical Trial at ESMO Congress 2026 Pilatus Biosciences, a biopharmaceutical company focused on developing novel metabolic checkpoint immunotherapies for cancer, announced that its…
Corcept Therapeutics Names Justin Gunn President of Endocrinology Division as Sean Maduck Retires Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on developing and commercializing medicines that modulate…
Cellares and Seoul National University Hospital Partner to Automate Manufacturing of Gene-Modified HSPC Therapy for PNH Cellares, an Integrated Development and Manufacturing Organization (IDMO), and Seoul National University Hospital (SNUH),…
NeuPath Health to Host 2026 Physician Forum Focused on Advances in Chronic and Musculoskeletal Pain Care NeuPath Health Inc. (TSXV: NPTH), a Canadian healthcare company operating one of the country’s…
Aurion Biotech Completes Enrollment in U.S. Phase 3 ASTRA Study of Regenerative Cell Therapy AURN001 Aurion Biotech, Inc., a commercial-stage regenerative cell therapy company focused on restoring vision, has announced…
ImmunoScape Appoints Peter Olagunju as CEO to Advance TCR-Based Cancer Immunotherapy Platform Toward the Clinic ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI, has appointed Peter…
StandardX Raises £10 Million to Build Scalable Isotope Refinery for Medicine and Fusion Energy StandardX, a UK-headquartered European deep technology company founded in 2025, has raised £10 million in seed…